MANAGEMENT TEAM
Robert S. Mills President and Chief Executive Officer
Mr. Mills joined Columbia in May 2001 as senior vice president, operations. He was named chief operating officer in September 2003, at which time he assumed full responsibility for R&D, including the preterm study. In January 2006, Mr. Mills was appointed president and was elected to the Company’s Board of Directors. Prior to joining Columbia, Mr. Mills served five years as Senior Vice President, Manufacturing Operations, at Watson Pharmaceuticals. During his 30-year career in the pharmaceutical industry he also served as Vice President, Operations, at Alpharma, Inc. and held various positions with Aventis, SA, including Director-Plant Operations. Mr. Mills holds a B.S. from Grove City College.
Michael McGrane Senior Vice President, General Counsel and Secretary
Mr. McGrane served as Vice President, General Counsel and Secretary since January 2002 and was promoted to Senior Vice President in January 2006. He joined Columbia from The Liposome Company, Inc., a biotechnology company, where he served as Vice President, General Counsel and Secretary, prior to which he was Vice President, General Counsel and Secretary to Novartis Consumer Health, Inc. Previously, Mr. McGrane held various positions with Novartis Pharmaceuticals Corporation, including Associate General Counsel, and was Regulatory Counsel to the U.S. Food and Drug Administration. Mr. McGrane received his J.D. degree from Georgetown University and his B.A. degree from Cornell College. He is a member of the New Jersey bar.
James Meer Senior Vice President, Chief Financial Officer and Treasurer
Mr. Meer joined Columbia Laboratories as Senior Vice President, Chief Financial Officer and Treasurer in December 2006. He has over 35 years of financial experience in both privately and publicly held companies, of which 15 years were in the life sciences industry. He most recently served as Senior Vice President, Chief Financial Officer, Secretary and Treasurer of Pharmos Corporation, a NASDAQ-traded biotechnology company, prior to which, Mr. Meer was a consultant to specialty pharmaceutical and biotech firms providing strategic and financial advice. He previously served eight years as Vice President and Treasurer of Schein Pharmaceutical, Inc. where he was responsible for capital formation, including a successful IPO, strategic planning and investor relations. He also held senior financial positions with public companies including EnviroSource, Inc., John Labatt Ltd. and General Host Corporation. Mr. Meer holds an MBA degree from Pace University and a BA degree in Economics from Rutgers College.
George W. Creasy M.D., FACOG Vice President, Clinical Research and Development
Dr. Creasy joined Columbia Laboratories as Vice President, Clinical Research and Development in November 2003. Before joining the Company, he was responsible for clinical development and management of reproductive health products in his more than 16 years with Johnson & Johnson. He was a faculty member of Penn State's Hershey Medical Center prior to starting his pharmaceutical career. A trained Obstetrician and Gynecologist, Dr. Creasy is a graduate of the Pennsylvania State University School of Medicine and a Fellow of the American College of Obstetricians and Gynecologists.